肝细胞癌中预测肿瘤簇包裹血管的CT与MRI个体内比较
回顾性纳入324例手术确诊肝细胞癌患者,分为发现队列227例和验证队列97例,分别建立基于CT和MRI的VETC预测评分模型。验证队列中CT模型与MRI模型预测VETC阳性肝细胞癌的敏感度、特异度和AUC无统计学显著差异。
要点
- VETC阳性肝细胞癌在CT和MRI上更常见肿瘤>5.0 cm、坏死或严重缺血、边缘不光滑、靶样表现、瘤内动脉及分隔或环状结构不均匀强化。
- VETC阳性肝细胞癌较VETC阴性者更常归为LI-RADS LR-M。
- 验证队列中CT模型与MRI模型预测VETC的敏感度、特异度和AUC无统计学显著差异。
核心结论
- 术前CT与MRI在识别VETC阳性肝细胞癌方面表现相当,均显示出有前景的预测能力。
研究设计与样本
- 回顾性纳入324例经手术确诊的肝细胞癌患者,均于2019年6月至2020年8月行术前动态CT和细胞外对比剂MRI,分为发现队列227例和验证队列97例。
关键影像表现/征象
- VETC阳性肝细胞癌在CT和MRI上均较VETC阴性者更常见肿瘤>5.0 cm、坏死或严重缺血、边缘不光滑、靶样表现、瘤内动脉及分隔或环状结构不均匀强化(所有p<0.05)。
- VETC阳性肝细胞癌较VETC阴性者更常归为LI-RADS LR-M(所有p<0.05)。
诊断标准与关键数值
- 验证队列中,CT模型预测VETC阳性肝细胞癌的敏感度为76.7%,MRI模型为86.7%(p=0.375)。
- 验证队列中,CT模型特异度为83.6%,MRI模型为74.6%(p=0.180)。
- 验证队列中,CT模型AUC为0.80,MRI模型为0.81(p=0.910)。
临床应用与阅片要点
- 术前CT和MRI均可用于预测肝细胞癌VETC模式,两者预测能力相当。
- 阅片时注意肿瘤>5.0 cm、坏死或严重缺血、边缘不光滑、靶样表现、瘤内动脉及分隔或环状结构不均匀强化等征象,并关注LI-RADS LR-M分类。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To establish and validate scoring models for predicting vessels encapsulating tumor clusters (VETC) in hepatocellular carcinoma (HCC) using computed tomography (CT) and magnetic resonance imaging (MRI), and to intra-individually compare the predictive performance between the two modalities.
METHODS: We retrospectively included 324 patients with surgically confirmed HCC who underwent preoperative dynamic CT and MRI with extracellular contrast agent between June 2019 and August 2020. These patients were then divided into a discovery cohort (n = 227) and a validation cohort (n = 97). Imaging features and Liver Imaging Reporting and Data System (LI-RADS) categories of VETC-positive HCCs were evaluated. Logistic regression analyses were conducted on the discovery cohort to identify clinical and imaging predictors associated with VETC-positive cases. Subsequently, separate CT-based and MRI-based scoring models were developed, and their diagnostic performance was compared using generalized estimating equations.
RESULTS: On both CT and MRI, VETC-positive HCCs exhibited a higher frequency of size > 5.0 cm, necrosis or severe ischemia, non-smooth tumor margin, targetoid appearance, intratumor artery, and heterogeneous enhancement with septations or irregular ring-like structure compared to VETC-negative HCCs (all p < 0.05). Regarding LI-RADS categories, VETC-positive HCCs were more frequently categorized as LR-M than VETC-negative cases (all p < 0.05). In the validation cohort, the CT-based model showed similar sensitivity (76.7% vs. 86.7%, p = 0.375), specificity (83.6% vs. 74.6%, p = 0.180), and area under the curve value (0.80 vs. 0.81, p = 0.910) to the MRI-based model in predicting VETC-positive HCCs.
CONCLUSION: Preoperative CT and MRI demonstrated comparable performance in the identification of VETC-positive HCCs, thus displaying promising predictive capabilities.
CLINICAL RELEVANCE STATEMENT: Both computed tomography and magnetic resonance imaging demonstrated promise in preoperatively identifying the vessel-encapsulating tumor cluster pattern in hepatocellular carcinoma, with no statistically significant difference between the two modalities, potentially adding additional prognostic value.
KEY POINTS: Computed tomography (CT) and magnetic resonance imaging (MRI) show promise in the preoperative identification of vessels encapsulating tumor clusters-positive hepatocellular carcinoma (HCC). HCC with vessels encapsulating tumor cluster patterns were more frequently LR-M compared to those without. These CT and MRI models showed comparable ability in identifying vessels encapsulating tumor clusters-positive HCC.
引用
- Pan J, Huang H, Zhang S, et al. Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma. Eur Radiol. 2024. PMID: 38992109. doi:10.1007/s00330-024-10944-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。